DAWNSKYE702
DAWNSKYE702
Sex: F
Data Quality: 1 star
MS: 2 yrs
Type: Relapsing-Remitting
Sensation: None
Overall: Mild
Cognition: moderate
Vision: moderate
Speech: moderate
Swallowing: mild
Upper limb: moderate
Walking: moderate
DAWNSKYE702
Female, 42 years
LAS VEGAS, NV
Primary Condition
MS
Type
Relapsing-Remitting
First symptom
Aug 2009
Diagnosis
Aug 2009
See more

Treatment charts require Flash. If you have problems installing Flash, visit the FAQ for help.

Get Adobe Flash player

DAWNSKYE702's Rebif is for:

  • MS

DAWNSKYE702's side effects of Rebif:

DAWNSKYE702's Rebif History (Ongoing)
Rebif (interferon beta-1a subq injection)
44 mg M,W,F Sep 04 - 04, 2009
22 mg M,W,F Sep 04, 2009 - Last Update
Evaluations
Date Dosage MS (Multiple Sclerosis) Efficacy Side Effects Adherence Burden
Jul 05, 2011 22 mg M,W,F Led_efficacy_4Led_efficacy_4Led_efficacy_4Led_efficacy_4 MildMildMildMild AlwaysAlwaysAlwaysAlways SomewhatSomewhatSomewhatSomewhat
Date
Jul 05, 2011
Advice & Tips
It took a little while for me to get used to the idea of injecting myself. I have never been a real big fan of needles, but now it has become a habit like taking out the trash, I don't like to do it, but I know I have to.
Cost
< $25 monthly

About Rebif (Prescription Drug)

Rebif, a brand name for interferon beta-1a, is an immunomodulator used to prevent episodes of symptoms and slow the development of disability in patients with relapsing-remitting multiple sclerosis. It is given subcutaneously (under the skin) three times a week, ideally the same 3 days each week.

Learn more about Rebif in our Rebif Community Report.